Skip to Content
Merck
CN
  • Chondroprotective Effects of Wogonin in Experimental Models of Osteoarthritis in vitro and in vivo.

Chondroprotective Effects of Wogonin in Experimental Models of Osteoarthritis in vitro and in vivo.

Biomolecules & therapeutics (2015-09-04)
Jin Sung Park, Hyun Jae Lee, Dong Yeong Lee, Ho Seung Jo, Jin Hoon Jeong, Dong Hee Kim, Dae Cheol Nam, Choong Jae Lee, Sun-Chul Hwang
ABSTRACT

We evaluated the chondroprotective effects of wogonin by investigating its effects on the gene expression and production of matrix metalloproteinase-3 (MMP-3) in primary cultured rabbit articular chondrocytes, as well as on production of MMP-3 in the rat knee. Rabbit articular chondrocytes were cultured in a monolayer, and RT-PCR was used to measure interleukin-1β (IL-1β)-induced expression of MMP-3, MMP-1, MMP-13, a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4), and type II collagen. In rabbit articular chondrocytes, the effects of wogonin on IL-1β-induced production and proteolytic activity of MMP-3 were investigated using western blot analysis and casein zymography, respectively. The effect of wogonin on MMP-3 protein production was also examined in vivo. In rabbit articular chondrocytes, wogonin inhibited the expression of MMP-3, MMP-1, MMP-13, and ADAMTS-4, but increased expression of type II collagen. Furthermore, wogonin inhibited the production and proteolytic activity of MMP-3 in vitro, and inhibited production of MMP-3 protein in vivo. These results suggest that wogonin can regulate the gene expression and production of MMP-3, by directly acting on articular chondrocytes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
IL-1 beta human, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture